U.S. medical centers are seeking FDA authorization for the compassionate use — or expanded access — of Namodenoson for ...

A preclinical model developed at UT Southwestern Medical Center that recapitulates a rare infant-onset form of diabetes ...

This organoid contains the three main types of pancreas cells: acinar cells, ductal cells, and endocrine cells. Each of these cells plays a vital role. Acinar cells release enzymes that help break ...

Other types of exocrine tumors are less common but include: Pancreatic neuroendocrine cancer develops when abnormal endocrine cells grow uncontrollably and form a tumor. Endocrine cells ...

Malnutrition-related diabetes mellitus aka type 5 diabetes has been recently recognised as a form of the non-communicable disease. But is it treatable? Should you even care? Here’s all you need to ...

At its core, diabetes mellitus is about your body’s relationship with insulin, the hormone responsible for helping cells ...

The US Food and Drug Administration (FDA) has approved Exelixis’ Cabometyx (cabozantinib) to treat advanced neuroendocrine tumours (NETs).

3 NET are rare but increasingly diagnosed tumors that originate from neuroendocrine cells of the digestive tract, pancreas, lungs, and other organs. 1 The prognosis for advanced NET varies ...

Cabometyx is approved for treating well-differentiated pancreatic and extra-pancreatic neuroendocrine ... “Cabometyx is an oral tyrosine kinase inhibitor and inhibits certain receptors on the cell ...

The tumors begin in neuroendocrine cells – which have characteristics ... most often in the gastrointestinal tract, lungs, and pancreas. The number of people diagnosed with NETs has been ...

On March 28, the FDA approved Imfinzi for use in combination with gemcitabine and cisplatin as neoadjuvant treatment, ...